| 13107-070-05 |
13107-070 |
HUMAN PRESCRIPTION DRUG |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
TABLET |
ORAL |
20131127 |
N/A |
ANDA |
ANDA202424 |
Aurolife Pharma, LLC |
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 |
500 TABLET in 1 BOTTLE (13107-070-05) |
| 16714-952-01 |
16714-952 |
HUMAN PRESCRIPTION DRUG |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
TABLET |
ORAL |
20190320 |
N/A |
ANDA |
ANDA202424 |
NorthStar RxLLC |
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1 |
100 TABLET in 1 BOTTLE (16714-952-01) |
| 16714-953-01 |
16714-953 |
HUMAN PRESCRIPTION DRUG |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
TABLET |
ORAL |
20190320 |
N/A |
ANDA |
ANDA202424 |
NorthStar RxLLC |
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 |
100 TABLET in 1 BOTTLE (16714-953-01) |